The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis

Inflamm Bowel Dis. 2020 Sep 18;26(10):e132-e133. doi: 10.1093/ibd/izaa170.

Authors

Muhammad Aziz¹, Rawish Fatima¹, Hossein Haghbin¹, Wade Lee-Smith², Ali Nawras³

Affiliations

¹ Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USA.
² University of Toledo Libraries, Toledo, OH, USA.
³ Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, OH, USA.

No abstract available

Keywords: COVID-19; Crohn’s disease; SARS-CoV-2; inflammatory bowel disease; ulcerative colitis.

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Colitis, Ulcerative*
Coronavirus Infections*
Gastrointestinal Microbiome*
Humans
Incidence
Pandemics*
Peptidyl-Dipeptidase A
Pneumonia, Viral*
SARS-CoV-2

Substances

Peptidyl-Dipeptidase A